Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
-$151,583 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
12 quarters on record
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Derivatives in REPL
reported options exposure · as of Mar 31, 2026CallValue
$1,341,810
CallShares
175,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026J. Goldman & Co LP holds $186,196,918 across 52 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
779,570 | $30,005,649 | |
| 2 | ARDX |
Ardelyx, Inc.
|
3,000,513 | $17,973,072 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
235,260 | $17,665,673 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
938,870 | $16,880,882 | |
| 5 | CAPR |
Capricor Therapeutics, Inc.
|
541,522 | $16,462,268 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,268 | $12,569,307 | |
| 7 | VSTM |
Verastem, Inc.
|
1,680,752 | $8,907,985 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
15,664 | $5,046,784 |
All Filings in REPL
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,341,810 | 175,400 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $1,992,600 | 205,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $151,583 | 15,595 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $283,244 | 67,600 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $628,004 | 67,600 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $1,129,644 | 115,861 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,364,591 | 112,683 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $132,616 | 12,100 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $739,800 | 67,500 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $774,181 | 70,637 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,224,450 | 136,050 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $923,940 | 54,000 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $923,940 | 54,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $1,326,326 | 57,120 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $2,133,918 | 91,900 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $1,831,748 | 103,723 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,353,534 | 86,527 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||